Geographic patterns of Plasmodium falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquine

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 45, 2009, Pages 18883-18889

  Sá, Juliana Martha ^a   Twu, Olivia ^a   Hayton, Karen ^a   Reyes, Sahily ^a   Fay, Michael P ^a   Ringwald, Pascal ^b   Wellems, Thomas E ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Malaria; pfcrt; pfmdr1

Indexed keywords

AMODIAQUINE; CHLOROQUINE; DEETHYLAMODIAQUINE;

ANTIBIOTIC RESISTANCE; ARTICLE; DRUG RESPONSE; GENE; GENE MUTATION; GEOGRAPHIC DISTRIBUTION; HAPLOTYPE; IC 50; NONHUMAN; PFCRT GENE; PFMDR1 GENE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTOZOAL GENETICS; QUANTITATIVE TRAIT LOCUS; SOUTH AFRICA; TANZANIA;

AMINOQUINOLINES; AMODIAQUINE; ANIMALS; ANTIMALARIALS; ATP-BINDING CASSETTE TRANSPORTERS; CHLOROQUINE; DRUG RESISTANCE; GEOGRAPHY; MEMBRANE TRANSPORT PROTEINS; MUTATION; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; QUANTITATIVE TRAIT LOCI; SELECTION, GENETIC;

PLASMODIUM FALCIPARUM;

EID: 73149118025     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0911317106     Document Type: Article

References (71)

1. Burckhalter JH, et al. (1948) Aminoalkylphenols as antimalarials. II. (Heterocyclicamino)-a-amino-o-cresols: The synthesis of camoquin. J Am Chem Soc 70:1363-1373.
2. Ridley RG, HudsonAT(1998) Quinoline antimalarials. Exp Opin Ther Patents 8:121-136.
3. Fitch CD, Chevli R, Gonzalez Y (1974) Chloroquine-resistant Plasmodium falciparum: Effect of substrate on chloroquine and amodiaquin accumulation. Antimicrob Agents Chemother 6:757-762.
4. Spencer HC, et al. (1984) Amodiaquine more effective than chloroquine against Plasmodium falciparum malaria on Kenya coast. Lancet 1:956-957.
5. Olliaro P, et al. (1996) Systematic review of amodiaquine treatment in uncomplicated malaria. Lancet 348(9036):1196-1201.
6. Adjetey TA, et al. (2005) Evaluation of the therapeutic efficacy of amodiaquine versus chloroquine in the treatment of uncomplicated malaria in Abie, Cote-d'Ivoire. Bull Soc Pathol Exot 98:193-196.
7. WHO (2006) Guidelines for the Treatment of Malaria (WHO, Geneva).
8. Patel JC, Dalal SD (1954) Treatment of malaria with a single dose of amodiaquin (Camoquin). Ind J Malariol 8:71-76.
9. Shute GT, Ray AP, Sangalang R (1972) Preliminary studies on a Philippine strain of Plasmodium falciparum resistant to amodiaquine. J Trop Med Hyg 75:125-132.
10. Hall AP, Segal HE, Pearlman EJ, Phintuyothin P, Kosakal S (1975) Amodiaquine-resistant falciparum malaria in Thailand. Am J Trop Med Hyg 24:575-580.
11. Kremsner PG, et al. (1988) A comparative trial of three regimens for treating uncomplicated falciparum malaria in Acre, Brazil. J Infect Dis 158:1368-1371.
12. Sapak P, et al. (1991) Ineffectiveness of amodiaquine against Plasmodium falciparum malaria in symptomatic young children living in an endemic malarious area of Papua New Guinea. J Trop Pediatr 37:185-190.
13. Lemnge M, et al. (2006) High reinfection rate and treatment failures in children treated with amodiaquine for falciparum malaria in Muheza villages, Northeastern Tanzania. Am J Trop Med Hyg 75:188-193.
14. Sasi P, et al. (2009) In vivo and in vitro efficacy of amodiaquine against Plasmodium falciparum in an area of continued use of 4-aminoquinolines in East Africa. J Infect Dis 199:1575-1582.
15. Echeverry DF, et al. (2007) Short report: Polymorphisms in the pfcrt and pfmdr1 genes of Plasmodium falciparum and in vitro susceptibility to amodiaquine and desethylamodiaquine. Am J Trop Med Hyg 77:1034-1038.
16. Churchill FC, et al. (1985) Amodiaquine as a prodrug: Importance of metabolite(s) in the antimalarial effect of amodiaquine in humans. Life Sci 36:53-62.
17. Kublin JG, et al. (2003) Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. J Infect Dis 187:1870-1875.
18. Wang X, et al. (2005) Decreased prevalence of the Plasmodium falciparum chloroquine resistance transporter 76T marker associated with cessation of chloroquine use against P. falciparum malaria in Hainan, People's Republic of China.AmJ TropMedHyg72:410-414.
19. Mwai L, et al. (2009) Chloroquine resistance before and after its withdrawal in Kenya. Malar J 8:106.
20. Laufer MK, et al. (2006) Return of chloroquine antimalarial efficacy in Malawi. N Engl J Med 355:1959-1966.
21. Martin SK, Oduola AM, Milhous WK (1987) Reversal of chloroquine resistance in Plasmodium falciparum by verapamil. Science 235:899-901.
22. Mehlotra RK, et al. (2001) Evolution of a unique Plasmodium falciparum chloroquineresistance phenotype in association with pfcrt polymorphism in PapuaNewGuinea and South America. Proc Natl Acad Sci USA 98:12689-12694.
23. Wellems TE, Hayton K, Fairhurst RM (2009) The impact of malaria parasitism: From corpuscles to communities. J Clin Invest 119:2496-2505.
24. Fidock DA, et al. (2000) Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell 6:861-871.
25. Naude B, Brzostowski JA, Kimmel AR, Wellems TE (2005) Dictyostelium discoideum expresses amalaria chloroquine resistance mechanism upon transfection with mutant, but not wild type, Plasmodium falciparum transporter PfCRT J Biol Chem 280:25596-25603.
26. Reed MB, Saliba KJ, Caruana SR, Kirk K,CowmanAF (2000) Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature 403:906-909.
27. Sidhu AB, Valderramos SG, Fidock DA (2005) pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum. Mol Microbiol 57:913-926.
28. Hayton K, et al. (2008) Erythrocyte binding protein PfRH5 polymorphisms determine species-specific pathways of Plasmodium falciparum invasion. Cell Host Microbe 4:40-51.
29. Wellems TE, et al. (1990) Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross. Nature 345:253-255.
30. Ferdig MT, et al. (2004) Dissecting the loci of low-level quinine resistance in malaria parasites. Mol Microbiol 52:985-997.
31. Wellems TE, Plowe CV (2001) Chloroquine-resistant malaria. J Infect Dis 184:770-776.
32. Aderounmu AF (1984) In vitro assessment of the antimalarial activity of chloroquine and its major metabolites. Ann Trop Med Parasitol 78:581-585.
33. Ringwald P, Bickii J, Basco LK (1996) In vitro activity of antimalarials against clinical isolates of Plasmodium falciparum in Yaounde, Cameroon. Am J Trop Med Hyg 55:254-258.
34. Rieckmann KH (1971) Determination of the drug sensitivity of Plasmodium falciparum. J Am Med Assoc 217:573-578.
35. Ramanamirija JA, Deloron P, Biaud JM, Le Bras J, Coulanges P (1985) In vivo and in vitro sensitivity to 4-aminoquinolines of Plasmodium falciparum in Madagascar: Results of 2 years' study. Bull Soc Pathol Exot Filiales 78:606-614.
36. Mu J, et al. (2003) Multiple transporters associated with malaria parasite responses to chloroquine and quinine. Mol Microbiol 49:977-989.
37. Yuan J, et al. (2009) Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum. Nat Chem Biol 5:765-771.
38. Foote SJ, et al. (1990) Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum. Nature 345:255-258.
39. Schuurkamp GJ, Kereu RK (1989) Resistance of Plasmodium falciparum to chemotherapy with 4-aminoquinolines in the Ok Tedi area of Papua New Guinea. Papua New Guinea Med J 32:33-44.
40. Mehlotra RK, et al. (2005) Insight into the early spread of chloroquine-resistant Plasmodium falciparum infections in Papua New Guinea. J Infect Dis 192:2174-2179.
41. DaRe JT, et al. (2007) Microsatellite polymorphism within pfcrt provides evidence of continuing evolution of chloroquine-resistant alleles in Papua New Guinea. Malar J 6:34.
42. Chen N, et al. (2002) Short report: Molecular evaluation of the efficacy of chloroquine treatment of uncomplicated Plasmodium falciparum malaria in East Timor. Am J Trop Med Hyg 67:64-66.
43. Huaman MC, Yoshinaga K, Suryanatha A, Suarsana N, Kanbara H (2004) Short report: Polymorphisms in the chloroquine resistance transporter gene in Plasmodium falciparum isolates from Lombok, Indonesia. Am J Trop Med Hyg 71:40-42.
44. Chen N, et al. (2003) pfcrt allelic types with two novel amino acid mutations in chloroquine-resistant Plasmodium falciparum isolates from the Philippines. Antimicrob Agents Chemother 47:3500-3505.
45. Chen N, et al. (2005) Origin and dissemination of chloroquine-resistant Plasmodium falciparum with mutant pfcrt alleles in the Philippines. Antimicrob Agents Chemother 49:2102-2105.
46. Dittrich S, et al. (2005) Falciparum malaria in the north of Laos: The occurrence and implications of the Plasmodium falciparum chloroquine resistance transporter (pfcrt) gene haplotype SVMNT. Trop Med Int Health 10:1267-1270.
47. Vathsala PG, et al. (2004) Widespread occurrence of the Plasmodium falciparum chloroquine resistance transporter (pfcrt) gene haplotype SVMNT in P. falciparum malaria in India. Am J Trop Med Hyg 70:256-259.
48. Ursing J, Zakeri S, Gil JP, Bjorkman A (2006) Quinoline resistance-associated polymorphisms in the pfcrt, pfmdr1, and pfmrp genes of Plasmodium falciparum in Iran. Acta Trop 97:352-356.
49. Zakeri S, et al. (2008) Association of pfcrt but not pfmdr1 alleles with chloroquine resistance in Iranian isolates of Plasmodium falciparum. Am J Trop Med Hyg 78:633-640.
50. WHO Expert Committee on Malaria (1950) Summary Review of the Literature on Camoquin. (WHO, Geneva).
51. Alifrangis M, et al. (2006) Occurrence of the Southeast Asian/South American SVMNT haplotype of the chloroquine-resistance transporter gene in Plasmodium falciparum in Tanzania. J Infect Dis 193:1738-1741.
52. Mutabingwa TK, et al. (2005) Amodiaquine alone, amodiaquine+sulfadoxinepyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children:Afour-arm randomised effectiveness trial. Lancet 365:1474-1480.
53. Holmgren G, et al. (2007) Selection of pfmdr1 mutations after amodiaquine monotherapy and amodiaquine plus artemisinin combination therapy in East Africa. Infect Genet Evol 7:562-569.
54. Mita T, et al. (2004) Expansion of wild-type allele rather than back mutation in pfcrt explains the recent recovery of chloroquine sensitivity of Plasmodium falciparum in Malawi. Mol Biochem Parasitol 135:159-163.
55. Gama BE, et al. (2009) Chloroquine and sulphadoxine-pyrimethamine sensitivity of Plasmodium falciparum parasites in a Brazilian endemic area. Malar J 8:156.
56. de Almeida A, Arez AP, Cravo PV, do Rosario VE (2009) Analysis of genetic mutations associated with antimalarial drug resistance in Plasmodium falciparum from the Democratic Republic of East Timor. Malar J 8:59.
57. Mehlotra RK, et al. (2008) Discordant patterns of genetic variation at two chloroquine resistance loci in worldwide populations of the malaria parasite Plasmodium falciparum. Antimicrob Agents Chemother 52:2212-2222.
58. Moll K, et al. (2008) Methods in Malaria Research (American Type Culture Collection, Manassas, VA).
59. Smilkstein M, Sriwilaijaroen N, Kelly JX, Wilairat P, Riscoe M (2004) Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening. Antimicrob Agents Chemother 48:1803-1806.
60. Broman KW, Wu H, Sen S, Churchill GA (2003) R/qtl: QTL mapping in experimental crosses. Bioinformatics 19:889-890.
61. Sen S, Churchill GA (2001) A statistical framework for quantitative trait mapping. Genetics 159:371-387.
62. Payne EH, Sharp EA, NickelMD(1949) Parenteral use of camoquin hydrochloride as an antimalarial. Am J Trop Med Hyg 29:353-368.
63. Simeons ATW, Chhatre KD (1947) Preliminary report on a new synthetic antimalarial. Ind Med Gaz 82:255-257.
64. Mein RM, Rosado PNS (1948) Experiences with new medicines against malaria in the Amazon. Rev Serv Espec Saude Publ May:1059-1069 (in Portuguese).
65. Mein RM (1951) Camoquin in the treatment of human malaria. Am J Trop Med Hyg 31:212-217.
66. Ejercito A, DuqueM(1948) Preliminary report on CAM-AQI dihydrochloride (Miaquin, Camoquin) in treatment of human malaria. Phil Med Ass J Manila 24:633.
67. Hoekenga MT (1951) The treatment of malaria with a single dose of camoquin. Am J Trop Med Hyg S1-31:139-143.
68. Hoekenga MF (1950) Camoquin treatment of malaria, a preliminary report. Am J Trop Med Hyg 30:63-69.
69. Victor M, VillarejosM(1951) Experiences with amodiaquin (camoquin) a new synthetic antimalarial. Am J Trop Med Hyg 31:703-706.
70. Hoekenga MT (1952) Treatment of malaria with a single dose of amodiaquine or chloroquine. J Am Med Assoc 149:1369-1371.
71. Rieckmann KH (1966) A field study on the effects of a combination of cycloguanil pamoate and amodiquine against malaria in the Rabaul area ofNewGuinea.AmJ Trop Med Hyg 15:833-837.